About Us

The mission of Cancer Biology is to become one of the premier cancer research departments in the nation. We will realize this goal through building teams and bridges to translate our best research ideas into effective prevention, treatment and cure of cancer and by educating and training the future generation of cancer researchers.


03/07/2017 14:00 - NC1-202
Title: Loss of DHT Glucuronidation Enables Hormone Therapy Resistance

03/14/2017 14:00 - NC1-202
Title: "DNA methyltransferase Inhibitors target lung cancer cells by activating the IFN-regulated OAS-RNase L pathway"

03/21/2017 14:00 - NC1-202
Title: "In small cell lung cancer, the FACT inhibitor CBL0137 increases NOTCH1 expression and synergizes with cisplatin to target tumor-initiating cells"

03/28/2017 14:00 - NC1-202
Title: "CTLA-4 in cancer immunotherapy, challenges and opportunities"

04/11/2017 14:00 - NC1-202
Title: "Resistance mechanisms for targeted BCL-2 family inhibition in lymphoid malignancies"

04/18/2017 11:00 - NE1-205
Title: "Peritoneal Carcinomatosis From Ovarian Carcinoma: Intricate Interplay Between Tumor Cells and Their Microenvironment"


Department of Cancer Biology
Lerner Research Institute
9500 Euclid Avenue
Cleveland, Ohio 44195
Tel. 216-636-7532
Fax (216) 445-6269